Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Pinzi

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Molecules (Basel, Switzerland)|July 18, 2019
In Silico Repositioning of Cannabigerol as a Novel Inhibitor of the Enoyl Acyl Carrier Protein (ACP) Reductase (InhA)Luca Pinzi, Christian Lherbet, Michel Baltas, et al.
Pharmaceuticals (Basel, Switzerland)|August 29, 2024
Searching for Novel HDAC6/Hsp90 Dual Inhibitors with Anti-Prostate Cancer Activity: In Silico Screening and In Vitro EvaluationLuca Pinzi, Silvia Belluti, Isabella Piccinini, et al.
ACS Omega|September 9, 2021
Hydroxamic Acid Derivatives: From Synthetic Strategies to Medicinal Chemistry ApplicationsAndrea Citarella, Davide Moi, Luca Pinzi, et al.
Chemistryopen|October 11, 2021
Design and Synthesis of Hsp90 Inhibitors with B-Raf and PDHK1 Multi-Target ActivityLuca Pinzi, Francesca Foschi, Michael S Christodoulou, et al.
Molecules (Basel, Switzerland)|June 10, 2023
Insights into the Structural Conformations of the Tau Protein in Different Aggregation StatusLuca Pinzi, Nicolò Bisi, Claudia Sorbi, et al.
Current Medicinal Chemistry|September 3, 2021
Dual Targeting Strategies on Histone Deacetylase 6 (HDAC6) and Heat Shock Protein 90 (Hsp90)Davide Bonanni, Andrea Citarella, Davide Moi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|November 14, 2022
Structure-activity exploration of a small-molecule allosteric inhibitor of T790M/L858R double mutant EGFRFrancesca Foschi, Annachiara Tinivella, Valentina Crippa, et al.
Frontiers in Pharmacology|June 8, 2017
On the Integration of <i>In Silico</i> Drug Design Methods for Drug RepurposingEric March-Vila, Luca Pinzi, Noé Sturm, et al.
RSC Advances|April 15, 2022
Synthesis of potent and selective HDAC6 inhibitors led to unexpected opening of a quinazoline ringDavide Moi, Andrea Citarella, Davide Bonanni, et al.
Future Medicinal Chemistry|May 17, 2018
Identification of small-molecule EGFR allosteric inhibitors by high-throughput dockingFabiana Caporuscio, Annachiara Tinivella, Valentina Restelli, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Molecules (Basel, Switzerland)|July 18, 2019
In Silico Repositioning of Cannabigerol as a Novel Inhibitor of the Enoyl Acyl Carrier Protein (ACP) Reductase (InhA)Luca Pinzi, Christian Lherbet, Michel Baltas, et al.
Pharmaceuticals (Basel, Switzerland)|August 29, 2024
Searching for Novel HDAC6/Hsp90 Dual Inhibitors with Anti-Prostate Cancer Activity: In Silico Screening and In Vitro EvaluationLuca Pinzi, Silvia Belluti, Isabella Piccinini, et al.
ACS Omega|September 9, 2021
Hydroxamic Acid Derivatives: From Synthetic Strategies to Medicinal Chemistry ApplicationsAndrea Citarella, Davide Moi, Luca Pinzi, et al.
Chemistryopen|October 11, 2021
Design and Synthesis of Hsp90 Inhibitors with B-Raf and PDHK1 Multi-Target ActivityLuca Pinzi, Francesca Foschi, Michael S Christodoulou, et al.
Molecules (Basel, Switzerland)|June 10, 2023
Insights into the Structural Conformations of the Tau Protein in Different Aggregation StatusLuca Pinzi, Nicolò Bisi, Claudia Sorbi, et al.
Current Medicinal Chemistry|September 3, 2021
Dual Targeting Strategies on Histone Deacetylase 6 (HDAC6) and Heat Shock Protein 90 (Hsp90)Davide Bonanni, Andrea Citarella, Davide Moi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|November 14, 2022
Structure-activity exploration of a small-molecule allosteric inhibitor of T790M/L858R double mutant EGFRFrancesca Foschi, Annachiara Tinivella, Valentina Crippa, et al.
Frontiers in Pharmacology|June 8, 2017
On the Integration of <i>In Silico</i> Drug Design Methods for Drug RepurposingEric March-Vila, Luca Pinzi, Noé Sturm, et al.
RSC Advances|April 15, 2022
Synthesis of potent and selective HDAC6 inhibitors led to unexpected opening of a quinazoline ringDavide Moi, Andrea Citarella, Davide Bonanni, et al.
Future Medicinal Chemistry|May 17, 2018
Identification of small-molecule EGFR allosteric inhibitors by high-throughput dockingFabiana Caporuscio, Annachiara Tinivella, Valentina Restelli, et al.
Pageof 5